EMPIRIC ANTIFUNGAL THERAPY IN PATIENTS WITH FEBRILE NEUTROPENIA

被引：0
|
作者：
Nucci, M. [1 ]
机构：
[1] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Clin Med, Serv Hematol & Lab Micol, BR-21941 Rio De Janeiro, Brazil
来源：
DRUGS OF TODAY | 2010年 / 46卷
关键词：
CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; INVASIVE MOLD INFECTION; HIGH-RISK; COMPUTED-TOMOGRAPHY; ASPERGILLOSIS; GALACTOMANNAN; MANAGEMENT;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：13 / 20
页数：8
相关论文
共 50 条
  • [21] Economic aspects of empiric antibiotic therapy for febrile neutropenia in children with cancer
    Castagnola, E
    Paola, D
    Giacchino, R
    Rossi, R
    Viscoli, C
    SUPPORTIVE CARE IN CANCER, 1998, 6 (06) : 524 - 528
  • [22] Comparison of antipseudomonal beta-lactams for febrile neutropenia empiric therapy
    Click, Z.
    Varughese, C.
    Geswein, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (03) : 324 - 324
  • [23] Economic aspects of empiric antibiotic therapy for febrile neutropenia in children with cancer
    E. Castagnola
    Dimitri Paola
    Raffaella Giacchino
    Rossella Rossi
    Claudio Viscoli
    Supportive Care in Cancer, 1998, 6 : 524 - 528
  • [24] Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients
    Sezgin, Gulay
    Acipayam, Can
    Ozkan, Ayse
    Bayram, Ibrahim
    Tanyeli, Atila
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (11) : 4549 - 4553
  • [25] MEROPENEM VERSUS PIPERACILLIN-TAZOBACTAM AS EMPIRIC THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY PATIENTS
    Sezgin, G.
    Acipayam, C.
    Ozkan, A.
    Kupeli, S.
    Bayram, I.
    Tanyeli, A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 176 - 177
  • [26] Efficacy of piperacillin/tazobactam as initial empiric therapy of febrile neutropenia in patients with hematologic malignancy.
    Bow, EJ
    Noskin, GA
    Schwarer, AP
    Laverdiere, M
    Vesole, DH
    BLOOD, 2003, 102 (11) : 281A - 281A
  • [27] Febrile neutropenia: antifungal prophylaxis
    Donnelly, JP
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (02) : 127 - 130
  • [28] Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia
    Hahn-Ast, C.
    Felder, L.
    Mayer, K.
    Mueckter, S.
    Ruhnke, M.
    Hein, R.
    Hellmich, M.
    Schwab, K.
    Rachow, T.
    Brossart, P.
    von Lilienfeld-Toal, M.
    ANNALS OF HEMATOLOGY, 2016, 95 (06) : 1001 - 1009
  • [29] Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia
    C. Hahn-Ast
    L. Felder
    K. Mayer
    S. Mückter
    M. Ruhnke
    R. Hein
    M. Hellmich
    K. Schwab
    T. Rachow
    P. Brossart
    M. von Lilienfeld-Toal
    Annals of Hematology, 2016, 95 : 1001 - 1009
  • [30] Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study
    Hiroki Mizuno
    Masashi Sawa
    Masamitsu Yanada
    Mizuho Shirahata
    Masato Watanabe
    Tomonori Kato
    Hirokazu Nagai
    Yukiyasu Ozawa
    Takanobu Morishita
    Motohiro Tsuzuki
    Emi Goto
    Akane Tsujimura
    Ritsuro Suzuki
    Yoshiko Atsuta
    Nobuhiko Emi
    Tomoki Naoe
    International Journal of Hematology, 2013, 98 : 231 - 236
12345